These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2213509)

  • 1. Monte Carlo simulation of HIV infection in an intravenous drug user community.
    Peterson D; Willard K; Altmann M; Gatewood L; Davidson G
    J Acquir Immune Defic Syndr (1988); 1990; 3(11):1086-95. PubMed ID: 2213509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the effects of drug misuse on HIV/AIDS prevalence.
    Bhunu CP; Mushayabasa S
    Theory Biosci; 2013 Jun; 132(2):83-92. PubMed ID: 23225069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India.
    Phukan SK; Medhi GK; Mahanta J; Adhikary R; Thongamba G; Paranjape RS; Akoijam BS
    Harm Reduct J; 2017 Jul; 14(1):41. PubMed ID: 28673303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of needle-exchange programs on the spread of HIV among injection drug users: a simulation study.
    Raboud JM; Boily MC; Rajeswaran J; O'Shaughnessy MV; Schechter MT
    J Urban Health; 2003 Jun; 80(2):302-20. PubMed ID: 12791806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injecting drug use and HIV infection in southwest China.
    Zheng X; Tian C; Choi KH; Zhang J; Cheng H; Yang X; Li D; Lin J; Qu S; Sun X
    AIDS; 1994 Aug; 8(8):1141-7. PubMed ID: 7986413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users.
    Murray JM; Law MG; Gao Z; Kaldor JM
    Int J Epidemiol; 2003 Oct; 32(5):708-14. PubMed ID: 14559736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China.
    Wu Z; Luo W; Sullivan SG; Rou K; Lin P; Liu W; Ming Z
    AIDS; 2007 Dec; 21 Suppl 8():S115-22. PubMed ID: 18172379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simulation model of the dynamics of HIV transmission in intravenous drug users.
    Atkinson J
    Comput Biomed Res; 1996 Aug; 29(4):338-49. PubMed ID: 8812079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV infection in females dependent on drugs.
    Wai BH; Singh S; Varma SL
    Addiction; 1996 Mar; 91(3):435-8. PubMed ID: 8867206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social context of needle selling in Baltimore, Maryland.
    Latkin CA; Davey MA; Hua W
    Subst Use Misuse; 2006; 41(6-7):901-13. PubMed ID: 16809178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the determinants of safe injecting and condom use among injecting drug users.
    Myers T; Millson M; Rigby J; Ennis M; Rankin J; Mindell W; Strathdee S
    Addiction; 1995 Feb; 90(2):217-26. PubMed ID: 7703815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. People and places: behavioral settings and personal network characteristics as correlates of needle sharing.
    Latkin C; Mandell W; Vlahov D; Oziemkowska M; Celentano D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov; 13(3):273-80. PubMed ID: 8898673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among injecting drug users in Catalonia].
    Huntington S; Folch C; González V; Meroño M; Ncube F; Casabona J
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):236-8. PubMed ID: 19695744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV in injecting drug users in Edinburgh: prevalence and correlates.
    Davies AG; Dominy NJ; Peters A; Bath GE; Burns SM; Richardson AM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):399-405. PubMed ID: 7882106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adolescents, sex and injecting drug use: risks for HIV infection.
    Barnard M; McKeganey N
    AIDS Care; 1990; 2(2):103-16. PubMed ID: 2085532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Operating needle exchange programmes in the hills of Thailand.
    Gray J
    AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
    Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
    Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural risk factors and HIV infection of injection drug users at detoxification clinics in Puerto Rico.
    Robles RR; Colón HM; Díaz N; Cancel LI; MacGowan R; Cole GE; Allen DM
    Int J Epidemiol; 1994 Jun; 23(3):595-601. PubMed ID: 7960388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.